Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma - PubMed (original) (raw)
. 2012 Jul 5;120(1):143-54.
doi: 10.1182/blood-2011-09-379156. Epub 2012 May 24.
Affiliations
- PMID: 22627769
- DOI: 10.1182/blood-2011-09-379156
Free article
Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma
Elodie Bégué et al. Blood. 2012.
Free article
Abstract
A molecular feature of Sézary syndrome (SS) is the abnormal expression of T-plastin by malignant T cells. Herein, we investigated the molecular mechanisms involved in T-plastin synthesis and the functions of this actin-binding protein, with a special interest in chemoresistance and migration. We confirm the specific expression of T-plastin in peripheral blood lymphocytes (PBLs) from SS patients and its total absence in PBLs from patients with mycosis fungoides, inflammatory cutaneous or hematologic diseases, and from healthy volunteers. Only 3 of 4 SS patients did constitutively express T-plastin. To assess whether T-plastin expression was inducible, T-plastin-negative PBLs were stimulated by phorbol 12-myristate 13-acetate and ionomycin. Our results demonstrate that T-plastin synthesis was induced in negative PBLs from SS patients, other studied patients, and healthy volunteers. Both constitutive and calcium-induced T-plastin expression was down-regulated by calcineurin inhibitors and involved nuclear factor of activated T cells transcription pathway. Constitutive T-plastin expression in SS was associated with resistance to etoposide-induced apoptosis and cell migration toward chemokines (TARC/CCL17, IP-10). In conclusion, T-plastin is a marker restricted to malignant lymphocytes from SS patients and plays a role for cell survival and migration. This opens new strategies for the treatment of SS advanced stages.
Similar articles
- T-plastin expression downstream to the calcineurin/NFAT pathway is involved in keratinocyte migration.
Brun C, Demeaux A, Guaddachi F, Jean-Louis F, Oddos T, Bagot M, Bensussan A, Jauliac S, Michel L. Brun C, et al. PLoS One. 2014 Sep 16;9(9):e104700. doi: 10.1371/journal.pone.0104700. eCollection 2014. PLoS One. 2014. PMID: 25226517 Free PMC article. - Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
Wong HK, Gibson H, Hake T, Geyer S, Frederickson J, Marcucci G, Caligiuri MA, Porcu P, Mishra A. Wong HK, et al. J Invest Dermatol. 2015 Aug;135(8):2084-2092. doi: 10.1038/jid.2015.116. Epub 2015 Mar 25. J Invest Dermatol. 2015. PMID: 25806852 - T-plastin (PLS3) gene expression differentiates Sézary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression.
Tang N, Gibson H, Germeroth T, Porcu P, Lim HW, Wong HK. Tang N, et al. Br J Dermatol. 2010 Feb 1;162(2):463-6. doi: 10.1111/j.1365-2133.2009.09587.x. Epub 2009 Nov 30. Br J Dermatol. 2010. PMID: 19995369 Free PMC article. - Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Jawed SI, et al. J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. J Am Acad Dermatol. 2014. PMID: 24438969 Review. - Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma.
Wong HK. Wong HK. Discov Med. 2013 Sep;16(87):71-8. Discov Med. 2013. PMID: 23998443 Review.
Cited by
- Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes.
Moerman-Herzog AM, Acheampong DA, Brooks AG, Blair SM, Hsu PC, Wong HK. Moerman-Herzog AM, et al. Oncotarget. 2019 Aug 20;10(49):5052-5069. doi: 10.18632/oncotarget.27120. eCollection 2019 Aug 20. Oncotarget. 2019. PMID: 31489115 Free PMC article. - Allosteric regulation controls actin-bundling properties of human plastins.
Schwebach CL, Kudryashova E, Agrawal R, Zheng W, Egelman EH, Kudryashov DS. Schwebach CL, et al. Nat Struct Mol Biol. 2022 Jun;29(6):519-528. doi: 10.1038/s41594-022-00771-1. Epub 2022 May 19. Nat Struct Mol Biol. 2022. PMID: 35589838 Free PMC article. - Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma.
Dulmage BO, Akilov O, Vu JR, Falo LD, Geskin LJ. Dulmage BO, et al. Oncotarget. 2019 May 3;10(33):3104-3113. doi: 10.18632/oncotarget.5742. eCollection 2019 May 3. Oncotarget. 2019. PMID: 31139323 Free PMC article. - Plastin 3 in health and disease: a matter of balance.
Wolff L, Strathmann EA, Müller I, Mählich D, Veltman C, Niehoff A, Wirth B. Wolff L, et al. Cell Mol Life Sci. 2021 Jul;78(13):5275-5301. doi: 10.1007/s00018-021-03843-5. Epub 2021 May 23. Cell Mol Life Sci. 2021. PMID: 34023917 Free PMC article. Review. - Lessons learned from gene expression profiling of cutaneous T-cell lymphoma.
Dulmage BO, Geskin LJ. Dulmage BO, et al. Br J Dermatol. 2013 Dec;169(6):1188-97. doi: 10.1111/bjd.12578. Br J Dermatol. 2013. PMID: 23937674 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical